DK385586D0 - Fremgangsmaade til fremstilling af en stabil modifikation af torasemid saavel som farmaceutisk praeparat, der indeholder torasemid - Google Patents
Fremgangsmaade til fremstilling af en stabil modifikation af torasemid saavel som farmaceutisk praeparat, der indeholder torasemidInfo
- Publication number
- DK385586D0 DK385586D0 DK385586A DK385586A DK385586D0 DK 385586 D0 DK385586 D0 DK 385586D0 DK 385586 A DK385586 A DK 385586A DK 385586 A DK385586 A DK 385586A DK 385586 D0 DK385586 D0 DK 385586D0
- Authority
- DK
- Denmark
- Prior art keywords
- torasemid
- preparing
- software
- procedure
- pharmaceutical preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853529529 DE3529529A1 (de) | 1985-08-17 | 1985-08-17 | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| DE3529529 | 1985-08-17 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK385586D0 true DK385586D0 (da) | 1986-08-13 |
| DK385586A DK385586A (da) | 1987-02-18 |
| DK162518B DK162518B (da) | 1991-11-11 |
| DK162518C DK162518C (da) | 1992-03-30 |
Family
ID=6278766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK385586A DK162518C (da) | 1985-08-17 | 1986-08-13 | Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US4743693A (da) |
| EP (1) | EP0212537B1 (da) |
| JP (2) | JPS6245576A (da) |
| KR (1) | KR930009818B1 (da) |
| AU (1) | AU573454B2 (da) |
| CA (1) | CA1307277C (da) |
| CS (2) | CS259891B2 (da) |
| DD (1) | DD259858A5 (da) |
| DE (2) | DE3529529A1 (da) |
| DK (1) | DK162518C (da) |
| ES (1) | ES2001522A6 (da) |
| FI (1) | FI82189C (da) |
| GR (1) | GR862139B (da) |
| HK (1) | HK59994A (da) |
| HU (1) | HU195778B (da) |
| IE (1) | IE59237B1 (da) |
| IL (1) | IL79672A (da) |
| LT (1) | LT3596B (da) |
| NO (1) | NO170079C (da) |
| NZ (1) | NZ217172A (da) |
| PL (1) | PL146086B1 (da) |
| PT (1) | PT83186B (da) |
| SU (1) | SU1480766A3 (da) |
| UA (1) | UA7080A1 (da) |
| ZA (1) | ZA866151B (da) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623620A1 (de) * | 1986-07-12 | 1988-01-21 | Boehringer Mannheim Gmbh | Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung |
| US5166162A (en) * | 1990-03-02 | 1992-11-24 | Adir Et Compagnie | Pyridylsulfonylurea and pyridylsulfonylthiourea compounds |
| JP3586471B2 (ja) * | 1991-06-25 | 2004-11-10 | 三菱ウェルファーマ株式会社 | トラセミド含有医薬組成物 |
| TW257757B (da) * | 1993-03-03 | 1995-09-21 | Boehringer Mannheim Gmbh | |
| HRP980532B1 (en) * | 1998-10-02 | 2005-06-30 | Pliva | Novel crystalline torasemide modification |
| US6166045A (en) | 1998-06-02 | 2000-12-26 | Roche Diagnostics Gmbh | Torasemide of modification III |
| US5914336A (en) | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
| US20030026835A1 (en) * | 1999-02-15 | 2003-02-06 | Sumitomo Pharmaceuticals Company Limited | Tablets disintegrating rapidly in the oral cavity |
| CN1378448A (zh) * | 1999-08-11 | 2002-11-06 | 特瓦制药工业有限公司 | 多晶型托拉塞米 |
| TR200401462T4 (tr) | 2000-02-17 | 2004-08-23 | Teva Pharmaceutical Industries Ltd. | Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu |
| HRP20020819A2 (en) | 2000-03-20 | 2004-12-31 | Teva Pharma | Novel processes for preparing torsemide intermediate |
| HRP20000162B1 (en) * | 2000-03-20 | 2004-06-30 | Pliva D D | Amorphous torasemide modification |
| HRP20000765A2 (en) * | 2000-11-10 | 2002-06-30 | Pliva D D | Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release |
| US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
| IN192178B (da) * | 2001-08-03 | 2004-03-06 | Ranbaxy Lab | |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| ITMI20020639A1 (it) * | 2002-03-27 | 2003-09-29 | Cosma S P A | Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea |
| HRP20020603B1 (en) * | 2002-07-19 | 2008-11-30 | Pliva D.D. | New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
| ES2237354T3 (es) * | 2002-11-18 | 2007-11-01 | Teva Pharmaceutical Industries Ltd. | Lansoprazol estable que contiene mas de 500 ppm, hasta aproximadamente 3.000 ppm de agua y mas de 200 ppm, hasta aproximadamente 5.000 ppm de alcohol. |
| CA2515130A1 (en) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Method of stabilizing lansoprazole |
| ES2244324B1 (es) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | Composiciones diureticas de liberacion prolongada. |
| AT500576B1 (de) * | 2004-07-28 | 2006-11-15 | Sanochemia Pharmazeutika Ag | Verfahren zur reindarstellung von kristallformen von torsemid |
| US10178893B1 (en) * | 2013-06-14 | 2019-01-15 | Scott Bradley Baker | Shoe |
| FR3018688A1 (fr) * | 2014-03-19 | 2015-09-25 | Virbac | Utilisation de torasemide a faible dose dans une composition veterinaire |
| EP3031471A1 (en) | 2014-12-12 | 2016-06-15 | Ceva Sante Animale | Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals |
| US12048677B2 (en) | 2014-12-12 | 2024-07-30 | Ceva Sante Animale | Compositions and uses thereof for the treatment of heart failure in domestic animals |
| DK3173075T3 (da) * | 2015-11-27 | 2019-01-21 | Accupharma Spolka Z Ograniczona Odpowiedzialnoscia | Farmaceutisk kombinationspræparat af ace-inhibitor og loopdiuretikum |
| CN115417810B (zh) * | 2022-09-22 | 2023-10-10 | 南京正科医药股份有限公司 | 一种托拉塞米晶型ⅰ的精制方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US30633A (en) * | 1860-11-13 | Improvement in fire-escapes | ||
| GB1477664A (en) * | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
| GB1593609A (en) * | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
| LU85193A1 (fr) * | 1984-01-31 | 1985-09-12 | Christiaens Sa A | Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation |
-
1985
- 1985-08-17 DE DE19853529529 patent/DE3529529A1/de active Granted
-
1986
- 1986-08-10 IL IL79672A patent/IL79672A/xx not_active IP Right Cessation
- 1986-08-11 AU AU61055/86A patent/AU573454B2/en not_active Expired
- 1986-08-11 CA CA000515676A patent/CA1307277C/en not_active Expired - Lifetime
- 1986-08-11 CS CS865945A patent/CS259891B2/cs not_active IP Right Cessation
- 1986-08-11 US US06/895,355 patent/US4743693A/en not_active Ceased
- 1986-08-12 PT PT83186A patent/PT83186B/pt unknown
- 1986-08-12 EP EP86111118A patent/EP0212537B1/de not_active Expired - Lifetime
- 1986-08-12 NZ NZ217172A patent/NZ217172A/xx unknown
- 1986-08-12 DE DE8686111118T patent/DE3667970D1/de not_active Expired - Lifetime
- 1986-08-13 DK DK385586A patent/DK162518C/da not_active IP Right Cessation
- 1986-08-13 IE IE217986A patent/IE59237B1/en not_active IP Right Cessation
- 1986-08-14 KR KR1019860006689A patent/KR930009818B1/ko not_active Expired - Lifetime
- 1986-08-14 GR GR862139A patent/GR862139B/el unknown
- 1986-08-14 DD DD86293655A patent/DD259858A5/de not_active IP Right Cessation
- 1986-08-14 ES ES8601131A patent/ES2001522A6/es not_active Expired
- 1986-08-15 SU SU864027953A patent/SU1480766A3/ru active
- 1986-08-15 ZA ZA866151A patent/ZA866151B/xx unknown
- 1986-08-15 NO NO863305A patent/NO170079C/no not_active IP Right Cessation
- 1986-08-15 PL PL1986261052A patent/PL146086B1/pl unknown
- 1986-08-15 FI FI863305A patent/FI82189C/fi not_active IP Right Cessation
- 1986-08-15 HU HU863598A patent/HU195778B/hu unknown
- 1986-08-15 UA UA4027953A patent/UA7080A1/uk unknown
- 1986-08-18 JP JP61191789A patent/JPS6245576A/ja active Granted
-
1987
- 1987-10-20 US US07/111,439 patent/US4822807A/en not_active Ceased
-
1989
- 1989-10-27 JP JP1278800A patent/JPH0643400B2/ja not_active Expired - Lifetime
-
1991
- 1991-12-31 CS CS914199A patent/CS419991A3/cs unknown
-
1992
- 1992-12-03 US US07/985,053 patent/USRE34580E/en not_active Expired - Lifetime
-
1993
- 1993-04-08 US US08/043,631 patent/USRE34672E/en not_active Expired - Lifetime
- 1993-08-27 LT LTIP898A patent/LT3596B/lt not_active IP Right Cessation
-
1994
- 1994-06-23 HK HK59994A patent/HK59994A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK385586A (da) | Fremgangsmaade til fremstilling af en stabil modifikation af torasemid saavel som farmaceutisk praeparat, der indeholder torasemid | |
| DK164408C (da) | Vaeksthormonfrigivende faktorforbindelser, forbindelserne til anvendelse som terapeutikum, fremgangsmaade til fremstilling af forbindelserne, farmaceutiske praeparater, der indeholder en effektiv maengde af en saadan forbindelse samt anvendelse af forbindelsen | |
| DK380986A (da) | Fremgangsmaade til fremstilling af piperidinderivater | |
| FI870155L (fi) | Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi | |
| DK204587A (da) | Fremgangsmaade til fremstilling af et opbevaringsstabilt koncentrat, til fremstilling af et desinficeringsmiddel | |
| FI871914L (fi) | Menetelmä oraalisen farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan | |
| FI871913L (fi) | Menetelmä oraalisen, farmaseuttisen valmisteen valmistamiseksi, joka on pysyvä värin muuttumista vastaan | |
| DK340785A (da) | Quinonderivater, fremgangsmaade til fremstilling af dem og farmaceutisk praeparat indeholdende dem | |
| DK110886D0 (da) | Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne | |
| DK345081A (da) | Fremgangsmaade til fremstilling af et stabilt vandigt praeparat indeholdende invermectin | |
| FI871492A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi | |
| DK583385A (da) | Fremgangsmaade til fremstilling af et stabilt nicorandilpraeparat | |
| NO883054L (no) | Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger. | |
| DK58688D0 (da) | Alkyl(heterocyclymethyl)phenethylamin-forbindelser, farmaceutiske praeparater indeholdende de alkylsulfonylaminosubstituerede forbindelser og anvendelse af disse til fremstilling af et laegemiddel til forhindring eller reduktion af hjertearrytmier | |
| DK349387D0 (da) | Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel | |
| DK220986A (da) | Fremgangsmaade til fremstilling af piperidyliden-dihydrodibenzo(a,d)cycloheptener og aza-derivater deraf, forbindelser vundet ved fremgangsmaaden og disses anvendelse til fremstilling af farmaceutiske kompositioner | |
| DK218985D0 (da) | Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem ogfremgangsmaade til fremstilling af dem | |
| DK601785D0 (da) | Fremgangsmaade til fremstilling af en hydrothermisk stabil zeolitkatalysator | |
| DK680787D0 (da) | Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse | |
| DK343386A (da) | Fremgangsmaade til fremstilling af 2-cyanamino-pyrimidin-derivater | |
| DK249083D0 (da) | Fremgangsmade til fremstilling af et pharmaceutisk praeparat til indgivelse af anti-androgent aktive forbindelser | |
| NL189334C (nl) | Therapeutisch preparaat dat catecholderivaten bevat. | |
| DK163058C (da) | Triazolethanolderivat, farmaceutiske praeparater indeholdende forbindelsen, forbindelsen til anvendelse som laegemiddel samt fremgangsmaade til fremstilling af forbindelsen | |
| DK164771C (da) | Fremgangsmaade til fremstilling af et nasalt farmaceutisk praeparat indeholdende ergot-cycliske peptidalkaloider | |
| DK669287D0 (da) | Farmaceutisk praerarat indeholdende en pyranoquinolinforbindelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |